Stevens Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Stevens Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-16,100	Closed	-$664K	–	1411
2015 Q2	$664K	Buy	+16,100	New	+$577K	0.02%	533
2015 Q1	–	Sell	-7,061	Closed	-$227K	–	1415
2014 Q4	$227K	Buy	+7,061	New	+$204K	0.01%	820

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Stevens Capital Management's BRLI Position: Q3 2015 in Review

Stevens Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 16,100 shares — an estimated $664K sold.

Stevens Capital Management first reported a position in BRLI in Q4 2014 and held it in 2 quarters. The position peaked at $664K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Stevens Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Stevens Capital Management sold 16,100 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $664K.
Stevens Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2014 and held it in 2 quarters.
Stevens Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $664K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Stevens Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.